Figure 3 — Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis | Aging

Navigate

Submit an Article

Research Paper|Volume 17, Issue 5|pp. 1313–1327

Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis

Back to articleFigure 3(3 of 3)

100%

Figure 3.Cochrane risk-of-bias assessment tool for randomized trials version 2.